SFX by Ex Libris Inc.

Title:	Scrapie Infectivity Is Independent of Amyloid Staining Properties of the N-Terminally Truncated Prion Protein
Source:	Journal of Structural Biology [1047-8477] Wille, Holger yr:2000

Basic

Full text

Full text available via EZB-NALI5-00465 Elsevier Archive NL

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Sipe, J D D. "Review: History of the amyloid fibril." Journal of structural biology 130.2-3 (2000): 88-98.
description	2.	Nilsson, Melanie R. "Techniques to study amyloid fibril formation in vitro." Methods 34.1 (2004): 151-160.
description	3.	ndrich, M. "On the structural definition of amyloid fibrils and other polypeptide aggregates." Cellular and molecular life sciences 64.16 (2007): 2066-2078.
description	4.	JARRETT, P T T. "AMYLOID FIBRIL FORMATION REQUIRES A CHEMICALLY DISCRIMINATING NUCLEATION EVENT - STUDIES OF AN AMYLOIDOGENIC SEQUENCE FROM THE BACTERIAL PROTEIN OSMB." Biochemistry 31.49 (1992): 12345-12352.
description	5.	Tycko, R. "Progress towards a molecular-level structural understanding of amyloid fibrils." Current opinion in structural biology 14.1 (2004): 96-103.
description	6.	Dobson, F. "Protein Misfolding, Functional Amyloid, and Human Disease." Annual review of biochemistry 75.1 (2006): 333-366.
description	7.	Serpell, LC C. "Alzheimer's amyloid fibrils: structure and assembly." Biochimica et biophysica acta. Molecular basis of disease 1502.1 (2000): 16-30.
description	8.	Dobson, Christopher M M. "Protein folding and misfolding." Nature 426.6968 (2003): 884-890.
description	9.	Lazar, Kristi L. [Author] L. "Helix-turn-helix peptides that form alpha-helical fibrils: Turn sequences drive fibril structure." Biochemistry 44.38 (2005): 12681-12689.
description	10.	Ross, Christopher A. "Protein aggregation and neurodegenerative disease." Nature medicine 10.Suppl (2004): 10-7.
description	11.	Hardy, J. "Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics." Science 297.5580 (2002): 353-356.
description	12.	Christopher M Dobson, Christopher M M. "An accidental breach of a protein's natural defenses." Nature structural & molecular biology 13.4: 295-7.
description	13.	Khurana, R. "Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates." Biochemistry 40.12 (2001): 3525-3535.
description	14.	Haass, C. "Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid Î²-peptide." Nature reviews. Molecular cell biology 8.2 (2007): 101-12.
description	15.	Stefani, M. "Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution." Journal of molecular medicine 81.11 (2003): 678-699.
description	16.	Herland, A. "Synthesis of a Regioregular Zwitterionic Conjugated Oligoelectrolyte, Usable as an Optical Probe for Detection of Amyloid Fibril Formation at Acidic pH." Journal of the American Chemical Society 127.7 (2005): 2317-2323.
description	17.	Chmelik, J. "Applications of field-flow fractionation in proteomics: Presence and future." Proteomics 7.16 (2007): 2719-2728.
description	18.	Ho, Meng-Ru R. "Human pancreatitis-associated protein forms fibrillar aggregates with a native-like conformation." The Journal of biological chemistry 281.44 (2006): 33566-33576.
description	19.	Wood, SJ. "Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide AP." Journal of molecular biology 256.5 (1996): 870-877.
description	20.	ASHBURN, TT. "INTERSPECIES SEQUENCE VARIATIONS AFFECT THE KINETICS AND THERMODYNAMICS OF AMYLOID FORMATION - PEPTIDE MODELS OF PANCREATIC AMYLOID." Journal of the American Chemical Society 115.23 (1993): 11012-11013.